Frontiers in Cellular Neuroscience (May 2020)
Lack of Helios During Neural Development Induces Adult Schizophrenia-Like Behaviors Associated With Aberrant Levels of the TRIF-Recruiter Protein WDFY1
- Anna Sancho-Balsells,
- Anna Sancho-Balsells,
- Anna Sancho-Balsells,
- Anna Sancho-Balsells,
- Veronica Brito,
- Veronica Brito,
- Veronica Brito,
- Veronica Brito,
- Belissa Fernández,
- Belissa Fernández,
- Belissa Fernández,
- Belissa Fernández,
- Mónica Pardo,
- Mónica Pardo,
- Mónica Pardo,
- Mónica Pardo,
- Marco Straccia,
- Marco Straccia,
- Marco Straccia,
- Marco Straccia,
- Marco Straccia,
- Silvia Ginés,
- Silvia Ginés,
- Silvia Ginés,
- Silvia Ginés,
- Jordi Alberch,
- Jordi Alberch,
- Jordi Alberch,
- Jordi Alberch,
- Jordi Alberch,
- Isabel Hernández,
- Belén Arranz,
- Josep M. Canals,
- Josep M. Canals,
- Josep M. Canals,
- Josep M. Canals,
- Josep M. Canals,
- Albert Giralt,
- Albert Giralt,
- Albert Giralt,
- Albert Giralt,
- Albert Giralt
Affiliations
- Anna Sancho-Balsells
- Departament de Biomedicina, Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona, Barcelona, Spain
- Anna Sancho-Balsells
- Institut de Neurociències, Universitat de Barcelona, Barcelona, Spain
- Anna Sancho-Balsells
- Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
- Anna Sancho-Balsells
- Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain
- Veronica Brito
- Departament de Biomedicina, Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona, Barcelona, Spain
- Veronica Brito
- Institut de Neurociències, Universitat de Barcelona, Barcelona, Spain
- Veronica Brito
- Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
- Veronica Brito
- Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain
- Belissa Fernández
- Departament de Biomedicina, Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona, Barcelona, Spain
- Belissa Fernández
- Institut de Neurociències, Universitat de Barcelona, Barcelona, Spain
- Belissa Fernández
- Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
- Belissa Fernández
- Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain
- Mónica Pardo
- Institut de Neurociències, Universitat de Barcelona, Barcelona, Spain
- Mónica Pardo
- Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
- Mónica Pardo
- Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain
- Mónica Pardo
- Laboratory of Stem Cells and Regenerative Medicine, Department of Biomedical Sciences, Faculty of Medicine and Health Science, University of Barcelona, Barcelona, Spain
- Marco Straccia
- Institut de Neurociències, Universitat de Barcelona, Barcelona, Spain
- Marco Straccia
- Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
- Marco Straccia
- Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain
- Marco Straccia
- Laboratory of Stem Cells and Regenerative Medicine, Department of Biomedical Sciences, Faculty of Medicine and Health Science, University of Barcelona, Barcelona, Spain
- Marco Straccia
- Faculty of Medicine and Health Science, Production and Validation Center of Advanced Therapies (Creatio), University of Barcelona, Barcelona, Spain
- Silvia Ginés
- Departament de Biomedicina, Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona, Barcelona, Spain
- Silvia Ginés
- Institut de Neurociències, Universitat de Barcelona, Barcelona, Spain
- Silvia Ginés
- Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
- Silvia Ginés
- Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain
- Jordi Alberch
- Departament de Biomedicina, Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona, Barcelona, Spain
- Jordi Alberch
- Institut de Neurociències, Universitat de Barcelona, Barcelona, Spain
- Jordi Alberch
- Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
- Jordi Alberch
- Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain
- Jordi Alberch
- Faculty of Medicine and Health Science, Production and Validation Center of Advanced Therapies (Creatio), University of Barcelona, Barcelona, Spain
- Isabel Hernández
- Alzheimer Research Center and Memory Clinic, Fundació ACE, Institut Català de Neurociències Aplicades. Barcelona, Spain
- Belén Arranz
- Parc Sanitari Sant Joan de Déu, CIBERSAM, Barcelona, Spain
- Josep M. Canals
- Institut de Neurociències, Universitat de Barcelona, Barcelona, Spain
- Josep M. Canals
- Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
- Josep M. Canals
- Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain
- Josep M. Canals
- Laboratory of Stem Cells and Regenerative Medicine, Department of Biomedical Sciences, Faculty of Medicine and Health Science, University of Barcelona, Barcelona, Spain
- Josep M. Canals
- Faculty of Medicine and Health Science, Production and Validation Center of Advanced Therapies (Creatio), University of Barcelona, Barcelona, Spain
- Albert Giralt
- Departament de Biomedicina, Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona, Barcelona, Spain
- Albert Giralt
- Institut de Neurociències, Universitat de Barcelona, Barcelona, Spain
- Albert Giralt
- Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
- Albert Giralt
- Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain
- Albert Giralt
- Faculty of Medicine and Health Science, Production and Validation Center of Advanced Therapies (Creatio), University of Barcelona, Barcelona, Spain
- DOI
- https://doi.org/10.3389/fncel.2020.00093
- Journal volume & issue
-
Vol. 14
Abstract
The role of the WDFY1 protein has been studied as a TLR3/4 scaffold/recruiting protein in the immune system and in different oncogenic conditions. However, its function in brain remains poorly understood. We have found that in mice devoid of Helios (He–/– mice), a transcription factor specifically expressed during the development of the immune cells and the central nervous system, there is a permanent and sustained increase of Wdfy1 gene expression in the striatum and hippocampus. Interestingly, we observed that WDFY1 protein levels were also increased in the hippocampus and dorsolateral prefrontal cortex of schizophrenic patients, but not in the hippocampus of Alzheimer’s disease patients with an associated psychotic disorder. Accordingly, young He–/– mice displayed several schizophrenic-like behaviors related to dysfunctions in the striatum and hippocampus. These changes were associated with an increase in spine density in medium spiny neurons (MSNs) and with a decrease in the number and size of PSD-95-positive clusters in the stratum radiatum of the CA1. Moreover, these alterations in structural synaptic plasticity were associated with a strong reduction of neuronal NF-κB in the pyramidal layer of the CA1 in He–/– mice. Altogether, our data indicate that alterations involving the molecular axis Helios-WDFY1 in neurons during the development of core brain regions could be relevant for the pathophysiology of neuropsychiatric disorders such as schizophrenia.
Keywords